FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com


Join the forum, it's quick and easy

FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com
FINANCIAL CHRONICLE™
Would you like to react to this message? Create an account in a few clicks or log in to continue.
FINANCIAL CHRONICLE™

Encyclopedia of Latest news, reviews, discussions and analysis of stock market and investment opportunities in Sri Lanka

Click Link to get instant AI answers to all business queries.
Click Link to find latest Economic Outlook of Sri Lanka
Click Link to view latest Research and Analysis of the key Sectors and Industries of Sri Lanka
Worried about Paying Taxes? Click Link to find answers to all your Tax related matters
Do you have a legal issues? Find instant answers to all Sri Lanka Legal queries. Click Link
Latest images

Latest topics

» TIME TO CALL SLT ?
by sureshot Today at 7:42 am

» Construction Sector Boom with Purchasing manager's indices
by rukshan1234 Yesterday at 11:24 pm

» Asha Securities and Asia Securities Target AEL (Access Enginnering PLC )
by Anushka Perz Wed Apr 17, 2024 10:30 pm

» Sri Lanka: China EXIM Bank Debt Moratorium to End in April 2024
by DeepFreakingValue Tue Apr 16, 2024 11:22 pm

» Uncertainty over impending elections could risk Lanka’s economic recovery: ADB
by God Father Tue Apr 16, 2024 2:47 pm

» Sri Lanka's Debt Restructuring Hits Roadblock with Bondholders
by God Father Tue Apr 16, 2024 2:42 pm

» BROWN'S INVESTMENTS SHOULD CONSIDER BUYING BITCOIN
by ADVENTUS Mon Apr 15, 2024 12:48 pm

» Bank run leading the way in 2024
by bkasun Sun Apr 14, 2024 3:21 pm

» ACCESS ENGINEERING PLC (AEL) Will pass IPO Price of Rs 25 ?????
by blindhog Thu Apr 11, 2024 10:44 am

» ASPI: Undoing GR/Covid19!
by DeepFreakingValue Thu Apr 11, 2024 10:25 am

» Learn CSE Rules and Regulations with the help of AI Assistant
by ChatGPT Tue Apr 09, 2024 7:47 am

» Top AI tools in Sri Lanka
by ChatGPT Tue Apr 09, 2024 7:21 am

» HDFC- Best ever profit reported in 2023
by ApolloCSE Mon Apr 08, 2024 12:43 pm

» WAPO 200% UP
by LAMDA Sun Apr 07, 2024 10:41 pm

» KEGALLE PLANTATIONS PLC (KGAL.N0000)
by DeepFreakingValue Fri Apr 05, 2024 2:04 pm

» ARPICO INSURANCE PLC - Reports LKR 625mn loss for the FY2023
by DeepFreakingValue Fri Apr 05, 2024 12:58 pm

» EXTERMINATORS PLC (EXT.N0000)
by ErangaDS Fri Apr 05, 2024 10:59 am

» ALLIANCE FINANCE COMPANY PLC (ALLI.N0000)
by SL-INVESTOR Fri Apr 05, 2024 8:29 am

» PEOPLE'S INSURANCE PLC (PINS.N0000)
by Anushka Perz Thu Apr 04, 2024 9:50 pm

» PINS (People's Insurance) will be another UAL
by sakuni Thu Apr 04, 2024 8:22 pm

» A New Record Price for One Tonne of Cocoa on the International Market
by ResearchMan Thu Apr 04, 2024 2:03 pm

» Access Engineering awarded two more contract packages at Colombo Port
by samansilva Thu Apr 04, 2024 12:05 pm

» FMCG Sector LMF, MEL and DIST
by buwr Thu Apr 04, 2024 9:35 am

» CEYLON GUARDIAN INVESTMENT TRUST PLC (GUAR)
by soileconomy Thu Apr 04, 2024 3:00 am

» RWSL - WATCH
by sureshot Wed Apr 03, 2024 8:39 am

LISTED COMPANIES

Submit Post
ශ්‍රී ලංකා මූල්‍ය වංශකථාව - සිංහල
Submit Post


CONATCT US


Send your suggestions and comments

* - required fields

Read FINANCIAL CHRONICLE™ Disclaimer



EXPERT CHRONICLE™

ECONOMIC CHRONICLE

GROSS DOMESTIC PRODUCT (GDP)



CHRONICLE™ YouTube

Disclaimer
FINANCIAL CHRONICLE™ Disclaimer

The information contained in this FINANCIAL CHRONICLE™ have been submitted by third parties directly without any verification by us. The information available in this forum is not researched or purported to be complete description of the subject matter referred to herein. We do not under any circumstances whatsoever guarantee the accuracy and completeness information contained herein. FINANCIAL CHRONICLE™ its blogs, forums, domains, subdomains and/or its affiliates and/or its web masters, administrators or moderators shall not in any way be responsible or liable for loss or damage which any person or party may sustain or incur by relying on the contents of this report and acting directly or indirectly in any manner whatsoever. Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility, FINANCIAL CHRONICLE™ blogs, forums, domains, subdomains and/or its affiliates and/or its web masters, administrators or moderators shall not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information. The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.

Further the writers and users shall not induce or attempt to induce another person to trade in securities using this platform (a) by making or publishing any statement or by making any forecast that he knows to be misleading, false or deceptive; (b) by any dishonest concealment of material facts; (c) by the reckless making or publishing, dishonestly or otherwise of any statement or forecast that is misleading, false or deceptive; or (d) by recording or storing in, or by means of, any mechanical, electronic or other device, information that he knows to be false or misleading in a material particular. Any action writers and users take in respect of (a),(b),(c) and (d) above shall be their own responsibility, FINANCIAL CHRONICLE™ its blogs, forums, domains, subdomains and/or its affiliates and/or its web masters, administrators or moderators shall not be liable for any, direct or indirect, consequential or incidental violation of securities laws of any country, damages or loss arising out of the use of this information.


AI Live Chat

You are not connected. Please login or register

COVID-19 Coronavirus Vaccine

Go down  Message [Page 1 of 1]

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

Health 09:35, 25-Oct-2020

[size=15]Translate



[size=36]Brazil institute to import 6 million doses of Chinese COVID-19 vaccine[/size]
Updated 16:01, 26-Oct-2020
CGTN[/size]
Share
COVID-19 Coronavirus Vaccine Facebook@3x[url=https://twitter.com/intent/tweet?text=Brazil institute to import 6 million doses of Chinese COVID-19 vaccine&url=https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html&via=cgtnofficial]COVID-19 Coronavirus Vaccine Twitter@3x[/url][url=http://service.weibo.com/share/share.php?appkey=4122844478&title=Brazil institute to import 6 million doses of Chinese COVID-19 vaccine&url=https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html&pic=&searchPic=true&style=simple]COVID-19 Coronavirus Vaccine Weibo@3x[/url]COVID-19 Coronavirus Vaccine Wechat@3x[email=?subject=Brazil%20institute%20to%20import%206%20million%20doses%20of%20Chinese%20COVID-19%20vaccine&body=I%20thought%20you%20might%20be%20interested%20in%20this%20news%3A%20https%3A%2F%2Fnews.cgtn.com%2Fnews%2F2020-10-25%2FBrazil-institute-to-import-6-million-does-of-Chinese-COVID-19-vaccine-URVu2jYtEc%2Findex.html.]COVID-19 Coronavirus Vaccine Mail@3x[/email]COVID-19 Coronavirus Vaccine Copy@3x

COVID-19 Coronavirus Vaccine E1bd8f4f828441529527dd3b091b0fff

A worker performs quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, September 24, 2020. /Reuters
Brazilian health regulator Anvisa on Friday authorized a biomedical center to import six million doses of the Sinovac coronavirus vaccine, one day after President Jair Bolsonaro said Brazil would not buy the Chinese vaccine.
Sao Paulo's Butantan Institute plans to initially import Sinovac's vaccine, which is in the third phase of trials conducted with the help of a local university and not yet approved for wider use in Brazil. Butantan would ultimately manufacture the vaccine if proven effective.
Brazil's Sao Paulo Governor Joao Doria said earlier on Friday that Anvisa told him it will not bow to political pressure over the approval of potential coronavirus vaccines.
According to the Brazilian state governors, the country will include China's Sinovac vaccine against COVID-19 in its national immunization program.
Joao said after the health ministry meeting that the federal government has agreed to buy 46 million doses of the Sinovac vaccine.
The program could begin in January 2021, he said, which could make it one of the first immunization efforts against the novel coronavirus in the world.
Sao Paulo State Health Secretary Jean Gorinchteyn said the vaccine appeared to produce protective antibodies. The state hopes to obtain regulatory approval for CoronaVac by the end of the year to start inoculating its population early in 2021, in what could be the first vaccination programs in the Americas.
In addition, another Brazilian pharmaceutical company was reported on Friday to have already signed an agreement with the Russian Direct Investment Fund (RDIF) to produce Russia's Sputnik V vaccine against COVID-19 starting in the second half of November.
The company said it was bound by a confidentiality agreement not to give any technical or scientific details. It still must obtain approval from Anvisa.
With more than 5.3 million cases of coronavirus reported in Brazil, the third worst outbreak after the United States and India, the South American country has become a testing ground in the race to find a vaccine.
Late stage trials are underway for vaccines under development by Oxford University/AstraZeneca, China's Sinovac Biotech, Pfizer Inc, in partnership with BioNTech and Johnson & Johnson's pharmaceutical subsidiary Janssen.
Brazil registered 432 additional coronavirus deaths over the last 24 hours and 26,979 new cases, the health ministry said on Saturday.
(With input from Reuters)

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

[size=39][size=39]Chinese partner says Pfizer COVID vaccine may reach market by December
BY 
GRADY MCGREGOR

October 27, 2020 11:39 AM GMT+5:30[/size][/size]

[size=14]
[size=14][size=14]Fosun chairman says Pfizer COVID vaccine could come as early as December 2020

Fosun Pharmaceuticals is Pfizer's Chinese partner in the development of the vaccine.



[/size][/size][/size]
Pause
[size][size][size]
Unmute
Loaded: 86.55%


 
[/size][/size][/size]
Fullscreen
[size][size][size]







COVID-19 Coronavirus Vaccine Play-button





[/size][/size][/size]
Close




  • [url=https://twitter.com/intent/tweet?text=Chinese partner says Pfizer COVID vaccine may reach market by december&url=https%3A%2F%2Ffortune.com%2F2020%2F10%2F27%2Fpfizer-vaccine-market-approval-biontech-fosun-china%2F][/url]
  • [url=https://www.linkedin.com/shareArticle/?url=https%3A%2F%2Ffortune.com%2F2020%2F10%2F27%2Fpfizer-vaccine-market-approval-biontech-fosun-china%2F&title=Chinese partner says Pfizer COVID vaccine may reach market by december&summary=Guo Guangchang%2C chairman of China%27s Fosun Group%2C is optimistic about his company%27s vaccine candidate.][/url]


[size][size]
[size=15]The experimental COVID-19 vaccine codeveloped by the U.S.’s [size=15]Pfizer, Germany’s BioNTech, and China's Fosun Pharmaceuticals may reach market as early as this December, according to the chairman of Fosun Group.
“Once the vaccine is proved to be safe and effective [after trial results are posted in November], the vaccine will be made available in the market by December [2020] or January next year,” Guo Guangchang, chair of the parent company of Fosun Pharmaceuticals, said Tuesday at the Fortune Global Forum.[/size][/size][/size][/size]

3COVID-19 Coronavirus Vaccine Empty COVID-19 Coronavirus Vaccine Wed Oct 28, 2020 3:34 am

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

COVID-19 Coronavirus Vaccine

  After long-term research and development and clinical trials, China has successfully developed a vaccine that effectively treats the new coronavirus infectious disease.
  Now the new vaccine has completed the third phase of clinical trials and approved for marketing;
  Due to the excessive global demand for vaccines, please contact us and make a order in advance.
  Quantity: ≤10000 doses/per day
COVID-19 Coronavirus Vaccine Contact-us-1

Sponsored content



Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum